Netflix faces wrongful termination suit from ex-executive over ketamine disclosure
Former Eyeline Studios executive Kevin Baillie sues Netflix for wrongful termination, citing a $1.1 million salary loss after disclosing prescribed ketamine therapy. The lawsuit alleges an internal investigation misinterpreted medical treatment as recreational drug use, contrasting with a permissive alcohol culture under Eyeline CEO Jeff Shapiro. The case emerges as Netflix reports Q2 revenue of $12.56 billion, missing estimates, while beating EPS expectations.

*this image is generated using AI for illustrative purposes only.
Netflix Inc. faces a wrongful termination lawsuit from Kevin Baillie, its former vice president and head of creative at Eyeline Studios, who alleges he was fired after disclosing medically prescribed ketamine therapy. Baillie claims the disclosure occurred during a workplace trust-building exercise in January 2026, sparking an internal investigation that led to his termination and the denial of up to one year of severance pay on a $1.1 million-a-year salary.
The lawsuit details that Baillie received physician-supervised ketamine therapy for depression in October and November 2022 at a Santa Barbara clinic following his mother's death. During a "Vulnerability-Trust exercise" at Netflix-owned Sendero Ranch in Northern California, Baillie shared this experience, explaining the treatment was prescribed for clinical depression. The complaint alleges that a company investigator raised the issue on March 18, 2026, suggesting suspicion of recreational drug use rather than accepting the medical context. Baillie was terminated the following month.
Allegations of Double Standards
Baillie’s complaint highlights alleged inconsistencies in Netflix’s enforcement of workplace conduct policies. The investigation reportedly examined allegations involving profanity and alcohol consumption during the same retreat. Baillie notes he had previously been advised during a performance review to reduce but not eliminate profanity. Additionally, the lawsuit references an incident where Baillie drank a Guinness while standing on his head after colleagues requested the demonstration during the trust exercise.
The suit further alleges that Eyeline Studios CEO Jeff Shapiro fostered an alcohol-friendly workplace culture. Baillie claims Shapiro brought beer on company outings, hosted parties, and maintained a bar in his office where he served alcohol to employees, including after a meeting with Netflix co-CEO Ted Sarandos.
Financial Context
The legal proceedings unfold as Netflix reported mixed financial results for the second quarter. The streaming giant posted revenue of $12.56 billion, a 13% year-over-year increase, though slightly below Wall Street expectations of $12.59 billion. Earnings per share reached 80 cents, surpassing analyst estimates of 79 cents per share.
| Metric | Q2 Actual | Analyst Estimate | YoY Change |
|---|---|---|---|
| Revenue | $12.56 billion | $12.59 billion | +13% |
| EPS | $0.80 | $0.79 | N/A |
For the third quarter, Netflix expects revenue of $12.86 billion, representing 12% year-over-year growth driven by gains in memberships, pricing, and advertising revenue. This guidance falls short of the Street’s consensus estimate of $13.01 billion. Netflix shares closed at $70.09 on Friday, up 1.74%, according to Benzinga Pro. The company did not immediately respond to requests for comment regarding the lawsuit.
How might this wrongful termination lawsuit influence Netflix's future workplace policies regarding employee disclosures of medical treatments and mental health support?
Could the allegations of inconsistent enforcement of conduct policies lead to broader regulatory scrutiny or class-action implications for Netflix's HR practices?
Will the negative publicity surrounding this lawsuit impact Netflix's ability to attract and retain top creative talent in a competitive streaming market?

































